EIP
NKGNW

Easterly Investment Partners’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Easterly Investment Partners’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$12K – 230
2021
Q3 		$12K Buy
+10,000
New +$12.5K ﹤0.01% 267

Other funds holding NKGNW

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return

Easterly Investment Partners's NKGNW Position: Q4 2021 in Review

Easterly Investment Partners sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q4 2021, closing a stake of 10,000 shares — an estimated $12K sold.

Easterly Investment Partners first reported a position in NKGNW in Q3 2021 and held it in 1 quarter. The position peaked at $12K in Q3 2021. 27 funds tracked by Wall St. Rank hold NKGNW as of Q4 2021.

  • Easterly Investment Partners reported no remaining NKGen Biotech, Inc. Warrants position as of Q4 2021 after selling out during the quarter.
  • Easterly Investment Partners sold 10,000 NKGen Biotech, Inc. Warrants shares in Q4 2021, an estimated $12K.
  • Easterly Investment Partners first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 1 quarter.
  • Easterly Investment Partners's NKGen Biotech, Inc. Warrants position peaked at $12K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q4 2021.

Based on Easterly Investment Partners's 13F filing for Q4 2021, filed 8 Feb 2022.